Glaukos Corp. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (125)

Latest Posts

About This Stock More About This Stock
Report From J.P.Morgan Healthcare Conference 2021: Current Portfolio Positions #1
Article By: Rod Raynovich
Thursday, January 14, 2021 5:42 AM EST
The Conference boosted many stocks as you might expect in a bull market for biotech. We reviewed rather quickly some of the presentations from the JPMorgan Healthcare Conference and will comment on specific companies and stocks in a series of posts.
In this article: ABT, BMY, GNMK, IBB, HOLX, PACB, XBI, ABBV, AXDX, GKOS, TDOC, VIR Also: AZN, GSK, MRNA, BNTX, JPM
Read
New Buy Ideas For 2020: Glaukos Corporation (GKOS)
Article By: Rod Raynovich
Thursday, January 30, 2020 2:17 AM EST
Glaukos new products are rolling out in 2020 so there is revenue and earnings risk because of new technology and competition.
In this article: IHI, GKOS Also: IBB, XBI, XLV
Read
Analyst Defends Glaukos After Reimbursement Cut Recommended
Article By: The Fly
Thursday, April 13, 2017 12:38 PM EST
After Noridian, a Medicare administrator, proposed drastically lowering the physician reimbursement rate for Glaukos' iStent implant, Wells Fargo sees the reduction as unjustified.
In this article: GKOS
Read
Glaukos Set To Sink Lower
Article By: Don Dion
Tuesday, April 11, 2017 9:27 AM EST
Glaukos is getting slammed and we think the slide will continue. At the market close on Monday, GKOS was already down over seven percent.
In this article: GKOS
Read
Insider Trading Report Edition 320: Notable Buys And Sales
Article By: Asif Suria
Sunday, August 7, 2016 3:22 AM EST
Insider buying decreased last week with insiders buying $78.59 million of stock compared to $118.43 million in the week prior. Selling was unchanged with insiders selling $2.12 billion of stock last week compared to $2.12 billion in the week prior.
In this article: KNX, LUV, PAG, RCL, INFN, AMZN, CELG, GRUB, GKOS Also: SPY
Read

Latest Tweets for $GKOS

No tweets yet!